Eisai Co., Ltd. et al v. MSN Pharmaceuticals Inc. > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Oct 21, 2020 | 13 | Patent/Trademark Report to Commissioner (5) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
Oct 15, 2020 | 12 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT (see document for further details). Signed by Judge Leonard P. Stark on 10/15/20. (ntl) |
Oct 13, 2020 | 11 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by Eisai Co., Ltd., Eisai Inc., Novartis Pharma AG. (Raucci, Anthony) |
Sep 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to Move, Answer or otherwise Respond to Complaint to October 21, 2020 filed by MSN Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 9/22/20. (ntl) |
Sep 21, 2020 | 9 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of MSN Pharmaceuticals Inc. (Myer, R.) |
Sep 21, 2020 | 10 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Move, Answer or otherwise Respond to Complaint to October 21, 2020 - filed by MSN Pharmaceuticals Inc.. (Myer, R.) |
Aug 3, 2020 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Eisai Inc., Eisai Co., Ltd., Novartis Pharma AG: For MSN Pharmaceuticals Inc. waiver sent on 7/23/2020, answer due 9/21/2020. (Blumenfeld, Jack) |
Jun 17, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
Jun 11, 2020 | 7 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
Jun 10, 2020 | 1 | Exhibit A (9) |
Jun 10, 2020 | 1 | Civil Cover Sheet (1) |
Jun 10, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
Jun 10, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 18, 2020. Date of Expiration of Patent: November 14, 2022. ** Pediatric exclusivity - May 14, 2023. Thirty Month Stay Deadline: 11/18/2022. (myr) |
Jun 10, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1. (myr) |
Jun 10, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eisai Co., Ltd. for Eisai Inc. filed by Eisai Co., Ltd., Eisai Inc. (myr) |
Jun 10, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharma AG filed by Novartis Pharma AG. (myr) |